{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T21:10:18Z","timestamp":1767474618052,"version":"3.37.3"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019158","name":"Fundaci\u00f3n Espa\u00f1ola de Reumatolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019158","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.semarthrit.2024.152604","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T16:50:40Z","timestamp":1733331040000},"page":"152604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Accrual of organ damage and one-year mortality in systemic sclerosis: A prospective observational study"],"prefix":"10.1016","volume":"70","author":[{"given":"Laura","family":"Cano-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aimara","family":"Garc\u00eda-Studer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2284-7846","authenticated-orcid":false,"given":"Sara","family":"Manrique-Arija","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Ortiz-M\u00e1rquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo","family":"Redondo-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Borreg\u00f3n-Garrido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Mena-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Fern\u00e1ndez-Nebro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10373","key":"10.1016\/j.semarthrit.2024.152604_bib0001","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0140-6736(22)01692-0","article-title":"Systemic sclerosis","volume":"401","author":"Volkmann","year":"2023","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.semarthrit.2024.152604_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241814287","article-title":"The pathogenesis of systemic sclerosis: the origin of fibrosis and interlink with vasculopathy and autoimmunity","volume":"24","author":"Ko","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152604_bib0003","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/art.24086","article-title":"The cost of systemic sclerosis","volume":"61","author":"Bernatsky","year":"2009","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152604_bib0004","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/ard.30.6.581","article-title":"Survival in scleroderma","volume":"30","author":"Bennett","year":"1971","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.semarthrit.2024.152604_bib0005","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152604_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102531","article-title":"Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014","volume":"19","author":"Scherlinger","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.semarthrit.2024.152604_bib0007","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/art.40027","article-title":"Early mortality in a multinational systemic sclerosis inception cohort","volume":"69","author":"Hao","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2024.152604_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163894","article-title":"Incidences and risk factors of organ manifestations in the early course of systemic sclerosis: a longitudinal EUSTAR study","volume":"11","author":"Jaeger","year":"2016","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.semarthrit.2024.152604_bib0009","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/rheumatology\/kex015","article-title":"Predictive value of European Scleroderma Group Activity Index in an early scleroderma cohort","volume":"56","author":"Nevskaya","year":"2017","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.semarthrit.2024.152604_bib0010","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1136\/annrheumdis-2019-215787","article-title":"Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual","volume":"78","author":"Fasano","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152604_bib0011","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1136\/annrheumdis-2018-214764","article-title":"Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis","volume":"78","author":"Ferdowsi","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.semarthrit.2024.152604_bib0012","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/art.24734","article-title":"Clinical and genetic factors predictive of mortality in early systemic sclerosis","volume":"61","author":"Assassi","year":"2009","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152604_bib0013","doi-asserted-by":"crossref","DOI":"10.55563\/clinexprheumatol\/2xiitt","article-title":"Long-term organ damage accrual and late mortality in systemic sclerosis","author":"Lazzaroni","year":"2023","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152604_bib0014","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/acr.24873","article-title":"Damage trajectories in systemic sclerosis using group-based trajectory modeling","volume":"75","author":"Barbacki","year":"2023","journal-title":"Arthritis Care Res"},{"issue":"4","key":"10.1016\/j.semarthrit.2024.152604_bib0015","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.semarthrit.2016.07.010","article-title":"Measures of disease status in systemic sclerosis: a systematic review","volume":"46","author":"Tay","year":"2017","journal-title":"Semin Arthritis Rheum"},{"issue":"17","key":"10.1016\/j.semarthrit.2024.152604_bib0016","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.3390\/jcm11175013","article-title":"Anemia is an indicator for worse organ damage trajectories in patients with systemic sclerosis: a retrospective study","volume":"11","author":"Li","year":"2022","journal-title":"J Clin Med"},{"issue":"11","key":"10.1016\/j.semarthrit.2024.152604_bib0017","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"Van Den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152604_bib0018","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ciresp.2010.05.012","article-title":"[Charlson index and the surgical risk scale in the analysis of surgical mortality]","volume":"88","author":"Gil-Bona","year":"2010","journal-title":"Cir Esp"},{"issue":"5","key":"10.1016\/j.semarthrit.2024.152604_bib0019","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.semarthrit.2024.152604_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114049","article-title":"Analysis of comorbidity in rheumatoid arthritis-associated interstitial lung disease: a nested case-cohort study","volume":"157","author":"Mena-V\u00e1zquez","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"10.1016\/j.semarthrit.2024.152604_bib0021","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","article-title":"Update of EULAR recommendations for the treatment of systemic sclerosis","volume":"76","author":"Kowal-Bielecka","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152604_bib0022","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.semarthrit.2024.152604_bib0023","unstructured":"Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser [Internet]. 2001\/03\/10. 2000 [cited 2023 Jan 15];894:i\u2013xii, 1\u2013253. Available from: http:\/\/ dx.doi.org\/."},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152604_bib0024","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","article-title":"EuroQol: the current state of play","volume":"37","author":"Brooks","year":"1996","journal-title":"Health Policy"},{"issue":"8","key":"10.1016\/j.semarthrit.2024.152604_bib0025","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/jama.1949.02900430001001","article-title":"Therapeutic criteria in rheumatoid arthritis","volume":"140","author":"Steinbrocker","year":"1949","journal-title":"J Am Med Assoc"},{"issue":"9","key":"10.1016\/j.semarthrit.2024.152604_bib0026","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1093\/rheumatology\/kead002","article-title":"Prediction of damage trajectories in systemic sclerosis using group-based trajectory modelling","volume":"62","author":"Baron","year":"2023","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152604_bib0027","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"Fanouriakis","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152604_bib0028","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s100670050039","article-title":"Acute-phase proteins in patients with systemic sclerosis","volume":"19","author":"Kucharz","year":"2000","journal-title":"Clin Rheumatol"},{"issue":"8","key":"10.1016\/j.semarthrit.2024.152604_bib0029","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1093\/rheumatology\/keaa827","article-title":"Health-related quality of life in patients with systemic sclerosis: evolution over time and main determinants","volume":"60","author":"Van Leeuwen","year":"2021","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152604_bib0030","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.rdc.2015.04.010","article-title":"Psychosocial aspects of scleroderma","volume":"41","author":"Kwakkenbos","year":"2015","journal-title":"Rheum Dis Clin N Am"},{"issue":"12","key":"10.1016\/j.semarthrit.2024.152604_bib0031","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1007\/s11136-019-02284-9","article-title":"Factors associated with quality of life in systemic sclerosis: a cross-sectional study","volume":"28","author":"Sierakowska","year":"2019","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152604_bib0032","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-019-1842-x","article-title":"Health-related quality of life in systemic sclerosis compared with other rheumatic diseases: a cross-sectional study","volume":"21","author":"Park","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"10.1016\/j.semarthrit.2024.152604_bib0033","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","article-title":"Mapping and predicting mortality from systemic sclerosis","volume":"76","author":"Elhai","year":"2017","journal-title":"Ann Rheum Dis"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017224002440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017224002440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T21:54:01Z","timestamp":1736200441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017224002440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":33,"alternative-id":["S0049017224002440"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152604","relation":{},"ISSN":["0049-0172"],"issn-type":[{"type":"print","value":"0049-0172"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Accrual of organ damage and one-year mortality in systemic sclerosis: A prospective observational study","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152604","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152604"}}